WHO ICTRP trial
A multicenter, double-blind, randomized controlled clinical study of…
ChiCTR2400085454 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400085454 |
|---|---|
| Public title | A multicenter, double-blind, randomized controlled clinical study of jianpiyishenhuazhuo granules in the treatment of vascular dementia |
| Scientific title | A multicenter, double-blind, randomized controlled clinical study ofJianpi Yishen Huazhuo granules in the treatment of vascular dementia |
| Primary sponsor | Xiyuan Hospital, China Academy of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | vascular dementia |
| Interventions | test group:Jianpi Yishen Huazhuo granules;control groups:Jianpi Yishen Huazhuo granules placebo |
| Registration date | Jun 7, 2024 |
| Target size | test group:165;control groups:165 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: